A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral robotic resection of HPV-related oropharyngeal cancersRobert M. Brody, Devraj Basu, David Shimunov et al.|Oral Oncology|2022Cited by 16
Author response: Repression of PRMT activities sensitize homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatmentYouyou Zhang, Xiaowen Hu, Junjie Jiang et al.|Unknown|2025Cited by 0